Fengzhou Li
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- RNA modifications and cancer 4
- RNA Research and Splicing 3
-
- Lung Cancer Treatments and Mutations 7
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- Chundong Gu (17 shared papers)Lei Fang (6 shared papers)Shilei Zhao (13 shared papers)Wendan Yu (6 shared papers)Wei Guo (5 shared papers)Wuguo Deng (4 shared papers)Yixiang Zhang (4 shared papers)Songyu Li (1 shared paper)
In The Last Decade
Fengzhou Li
26 papers receiving 539 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 149
- Oncology 157
- Immunology 93
- Molecular Biology 302
- Pulmonary and Respiratory Medicine 112
Countries citing papers authored by Fengzhou Li
This map shows the geographic impact of Fengzhou Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengzhou Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengzhou Li more than expected).
Fields of papers citing papers by Fengzhou Li
This network shows the impact of papers produced by Fengzhou Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengzhou Li. The network helps show where Fengzhou Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengzhou Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 120 | |
| 2 | 2021 | 54 | |
| 3 | 2020 | 49 | |
| 4 | α1,6-Fucosyltransferase (FUT8) regulates the cancer-promoting capacity of cancer-associated fibroblasts (CAFs) by modifying EGFR core fucosylation (CF) in non-small cell lung cancer (NSCLC). | 2020 | 34 |
| 5 | 2020 | 33 | |
| 6 | 2016 | 31 | |
| 7 | 2017 | 29 | |
| 8 | 2019 | 28 | |
| 9 | 2019 | 22 | |
| 10 | 2023 | 18 | |
| 11 | 2021 | 18 | |
| 12 | 2021 | 16 | |
| 13 | 2019 | 16 | |
| 14 | 2019 | 14 | |
| 15 | 2021 | 11 | |
| 16 | 2019 | 10 | |
| 17 | 2020 | 9 | |
| 18 | 2018 | 7 | |
| 19 | 2023 | 5 | |
| 20 | 2017 | 5 |
About Fengzhou Li
Fengzhou Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Epidemiology, having authored 26 papers that have together received 542 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers), Cancer Cells and Metastasis (3 papers), RNA Research and Splicing (3 papers), Dental Radiography and Imaging (3 papers), Lung Cancer Diagnosis and Treatment (3 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (149 citations), Oncology (157 citations), Immunology (93 citations), Molecular Biology (302 citations) and Pulmonary and Respiratory Medicine (112 citations). Fengzhou Li has collaborated with scholars based in China, Taiwan and Japan. Frequent co-authors include Chundong Gu, Lei Fang, Shilei Zhao, Wendan Yu, Wei Guo, Wuguo Deng, Yixiang Zhang, Songyu Li, Qingkai Yang and Zhuoshi Li. Their work appears in journals such as BioMed Research International, Cell Death and Disease, Human Cell, Clinical Oral Investigations and The International Journal of Biochemistry & Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.